Background and Biological Function of CENPK

Centromere Protein K (CENPK) is a constitutive centromere-associated protein that forms a stable component of the CENP-A Nucleosome-Associated Complex (CNAC), also referred to as the CCAN (Constitutive Centromere-Associated Network). This multi-subunit network provides the structural foundation upon which the kinetochore is assembled during cell division.

CENPK interacts with other CCAN subunits, including CENPC, CENPH, CENPM, CENPN, CENPP, CENPQ, CENPR, and CENPU, to maintain centromere identity and integrity throughout the cell cycle. Loss of CENPK function has been associated with defective kinetochore formation, chromosome misalignment, and mitotic errors that may contribute to genomic instability.

Recombinant Human CENPK Protein enables in vitro investigation of these interactions, making it a valuable reagent for pull-down assays, co-immunoprecipitation controls, structural studies, and antibody validation.

Materials and Equipment Required

• Recombinant Human CENPK Protein (SKU: rp377688)
• Sterile, nuclease-free deionized water or reconstitution buffer as specified on the Certificate of Analysis (CoA)
• Microcentrifuge tubes (1.5 mL, low-protein-binding recommended)
• Calibrated micropipettes and sterile tips
• Microcentrifuge capable of ≥10,000 × g
• –20 °C and –80 °C freezers
• Appropriate assay buffers (PBS, HEPES-based, or as required by downstream application)
• Protein quantification reagents (e.g., Bradford or BCA assay kit)
• SDS-PAGE and western blotting equipment (for quality verification)

Step-by-Step Reconstitution and Handling Protocol

Step 1 – Preparation. Allow the lyophilized protein vial to equilibrate to room temperature (18–25 °C) for 10–15 minutes before opening to minimize condensation and protein aggregation upon reconstitution.

Step 2 – Reconstitution. Add the volume of sterile reconstitution buffer specified in the Certificate of Analysis (CoA) slowly along the wall of the vial. Do not vortex. Gently swirl or roll the vial until the lyophilized cake is fully dissolved. Centrifuge briefly at ≤1,000 × g to consolidate the solution.

Step 3 – Protein Quantification. Determine protein concentration using a BCA or Bradford assay with BSA as the standard curve reference. Compare results with the theoretical concentration stated on the CoA.

Step 4 – Quality Verification. Run an aliquot on SDS-PAGE under reducing conditions and stain with Coomassie Blue or perform a western blot using an anti-CENPK antibody to confirm molecular weight and purity.

Step 5 – Aliquoting. Divide the reconstituted protein into single-use aliquots to avoid repeated freeze-thaw cycles, which can cause protein degradation and loss of activity.

Step 6 – Storage. Store short-term aliquots at –20 °C (up to 1 month) and long-term stocks at –80 °C. Do not store in a frost-free freezer. Adding a carrier protein such as 0.1% BSA may enhance stability during long-term storage; refer to the CoA for specific guidance.

Recommended Downstream Applications

Recombinant Human CENPK Protein is suitable for a range of in vitro and cell-free research applications, including but not limited to:

• Pull-down and co-immunoprecipitation (Co-IP) assays: Investigate protein–protein interactions between CENPK and other CCAN subunits or novel binding partners.
• Antibody validation: Use as a positive control antigen to validate anti-CENPK antibody specificity by western blot or ELISA.
• Enzyme-linked immunosorbent assay (ELISA): Serve as a coating antigen or standard for quantitative ELISA development.
• Structural and biophysical studies: Suitable as a component for size-exclusion chromatography, native PAGE, or surface plasmon resonance (SPR) binding studies.
• Cell-free functional assays: Explore the role of CENPK in centromere reconstitution or kinetochore assembly in vitro.

Optimal assay conditions, including buffer composition, protein concentration, and incubation parameters, should be empirically determined for each specific application.

Troubleshooting and Quality Control

Issue: Protein appears aggregated or insoluble after reconstitution.
Possible causes: Reconstitution buffer incompatibility, excessive temperature fluctuation, or vortexing. Recommendation: Centrifuge at ≥10,000 × g for 10 minutes at 4 °C to pellet aggregates; use the clarified supernatant. Consider adding mild detergent (e.g., 0.01% Tween-20) or optimizing salt concentration.

Issue: Molecular weight does not match expected value on SDS-PAGE.
Possible causes: Post-translational modifications, degradation, or gel calibration error. Recommendation: Verify gel molecular weight standards, check protein integrity by silver stain, and review CoA for expected molecular weight with any tags included.

Issue: Low activity or weak signal in downstream assay.
Possible causes: Protein degradation from freeze-thaw cycling, incorrect storage temperature, or suboptimal assay conditions. Recommendation: Use freshly thawed aliquots, confirm protein concentration by BCA assay, and optimize assay buffer and incubation conditions empirically.

Quality Control Checkpoint: Each lot of Recombinant Human CENPK Protein should be verified by SDS-PAGE or western blot prior to use in critical experiments. Retain a reference aliquot from each new lot for comparative benchmarking.